ZENITHDRUG — Zenith Drugs Balance Sheet
0.000.00%
- IN₹1.19bn
- IN₹1.67bn
- IN₹1.33bn
- 29
- 58
- 39
- 36
Annual balance sheet for Zenith Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | R2024 March 31st | 2025 March 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PRESS | PRESS |
Standards: | IAS | IAS | — | — |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Short Term Investments | 30 | 36.1 | 87.4 | 2.63 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 384 | 566 | 753 | 726 |
Total Inventory | ||||
Total Other Current Assets | ||||
Total Current Assets | 535 | 839 | 1,128 | 1,152 |
Net Property, Plant And Equipment | 131 | 117 | 148 | 432 |
Net Intangible Assets | ||||
Long Term Investments | ||||
Long Term Notes Receivable | ||||
Other Long Term Assets | ||||
Total Assets | 686 | 979 | 1,342 | 1,615 |
Accounts Payable | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 466 | 718 | 641 | 793 |
Long Term Debt | ||||
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Minority Interest | ||||
Total Other Liabilities | ||||
Total Liabilities | 565 | 807 | 720 | 921 |
Common Stock | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | 121 | 172 | 622 | 694 |
Total Liabilities & Shareholders' Equity | 686 | 979 | 1,342 | 1,615 |
Total Common Shares Outstanding |